PF4 and Thrombocytopenia: The antibody–antigen complex then causes platelet activation by binding to platelet FcγRIIA receptors, promoting a pro‐thrombotic state, that is, further release of PF4, platelet aggregation, release of procoagulant microparticles,7 as well as calpain‐dependent thrombocytopenia.9, 10